FDA inspection
Humanwell PuraCap Pharmaceuticals (Wuhan) Co., Ltd.: FDA inspection ending Jun 14, 2019
FDA inspection 1106763 · Voluntary Action Indicated (VAI) · Wuhan
Key facts
| Inspection ID | 1106763 |
|---|---|
| Firm | Humanwell PuraCap Pharmaceuticals (Wuhan) Co., Ltd. |
| FEI number | 3010163919 |
| Address | No. 99 2nd Shendun Road, East Lake, Technology Development Zone |
| City | Wuhan |
| Country | China |
| Fiscal year | 2019 |
| Inspection end date | Jun 14, 2019 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data